Advancing Medical Treatment and Science Worldwide
Microbiome-based therapies are a new frontier of medicine that present a promising option for patients who have exhausted standard treatments.
Since 2012, OpenBiome has developed a procedure called fecal microbiota transplantation (FMT) into the standard of care for patients with recurrent C. difficile infections.
We also push the boundaries of science by supporting clinical trials and building a globally-representative microbiome library.
Transforming Healthcare through Fecal Microbiota Transplantation
Healthcare facilities and research institutions in the United States have partnered with OpenBiome to treat patients and perform clinical trials
Patients with recurrent C. difficile infections have received urgently needed fecal microbiota transplantation (FMT) treatments manufactured by OpenBiome
Clinical trials exploring the therapeutic potential of the microbiome have received guidance and FMT preparations provided by OpenBiome.
“Not even three full days after the transplant and I feel like a new person. I actually got dressed today and went to the store. I haven’t been able to do that in months. I don’t know what we would have done if you hadn’t made this process known and available.”
— Patient who received an OpenBiome FMT in 2014
Our Global Mission
Understanding the human microbiome is critical for public health. But our current knowledge—largely focused on U.S. and European populations—is biased and vastly incomplete. This hinders certain groups from having equitable access to microbiome science and medicine.
OpenBiome, through our flagship program the Global Microbiome Conservancy, is building a globally representative library of the human microbiome to ensure that all communities have a chance to participate in and benefit from microbiome science.
Working in partnership with local scientists, we collect, analyze, and culture human microbiome diversity from underrepresented communities around the world. Samples and associated data from the GMbC collection will be available to scientists in the Spring of 2023 and expand their understanding of the microbiome and human health.
Global Microbiome Conservancy (GMbC) By the Numbers
Participants from underrepresented communities included in the GMbC library
Metagenomic surveys performed on individual stool samples to analyze bacterial composition
Genome-sequenced bacterial cultures prepared as a research tool
Research collaborators in more than three dozen countries worldwide